Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Spine
|
July 11, 2000
Can discography cause long-term back symptoms in previously asymptomatic subjects?
E J Carragee, Y Chen, C M Tanner, et al.
Clinical Neuropharmacology
|
June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia
A S Buchman, C L Comella, G T Stebbins, et al.
Neurology
|
August 1, 1989
Agonist substitution in advanced Parkinson's disease
C G Goetz, K M Shannon, C M Tanner, et al.
Neurology
|
May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)
C G Goetz, C M Tanner, H L Klawans, et al.
Spine
|
January 6, 2001
Provocative discography in patients after limited lumbar discectomy: A controlled, randomized study of pain response in symptomatic and asymptomatic subjects
E J Carragee, Y Chen, C M Tanner, et al.
Archives of Internal Medicine
|
October 1, 1986
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity
S M Sprague, H L Corwin, R S Wilson, et al.
European Journal of Pharmacology
|
January 21, 1986
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity
P M Carvey, L C Kao, C M Tanner, et al.
Clinical Neuropharmacology
|
December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's disease
K M Shannon, C G Goetz, V S Carroll, et al.
Advances in Neurology
|
January 1, 1983
Levodopa-free periods ("drug holidays") in the management of parkinsonism
H L Klawans, C G Goetz, C M Tanner, et al.
Advances in Neurology
|
January 1, 1982
Tourette-like symptoms following chronic neuroleptic therapy
H L Klawans, P A Nausieda, C C Goetz, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Spine
|
July 11, 2000
Can discography cause long-term back symptoms in previously asymptomatic subjects?
E J Carragee, Y Chen, C M Tanner, et al.
Clinical Neuropharmacology
|
June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia
A S Buchman, C L Comella, G T Stebbins, et al.
Neurology
|
August 1, 1989
Agonist substitution in advanced Parkinson's disease
C G Goetz, K M Shannon, C M Tanner, et al.
Neurology
|
May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)
C G Goetz, C M Tanner, H L Klawans, et al.
Spine
|
January 6, 2001
Provocative discography in patients after limited lumbar discectomy: A controlled, randomized study of pain response in symptomatic and asymptomatic subjects
E J Carragee, Y Chen, C M Tanner, et al.
Archives of Internal Medicine
|
October 1, 1986
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity
S M Sprague, H L Corwin, R S Wilson, et al.
European Journal of Pharmacology
|
January 21, 1986
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity
P M Carvey, L C Kao, C M Tanner, et al.
Clinical Neuropharmacology
|
December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's disease
K M Shannon, C G Goetz, V S Carroll, et al.
Advances in Neurology
|
January 1, 1983
Levodopa-free periods ("drug holidays") in the management of parkinsonism
H L Klawans, C G Goetz, C M Tanner, et al.
Advances in Neurology
|
January 1, 1982
Tourette-like symptoms following chronic neuroleptic therapy
H L Klawans, P A Nausieda, C C Goetz, et al.
Page
of 14